Portfolio of ASH journals including Blood, Blood Advances, Blood Global Hematology, Blood ICT, Blood Neoplasia, Blood RCI, and Blood VTH.
- Tweets 10,438
- Following 883
- Followers 54,467
- Likes 1,198
Pinned Tweet
New issue of Blood out now featuring A TAG team for achieving deep remissions in BPDCN, MEIS1 guardian USP22 fuels transcription in KMT2Ar leukemia, Securing HMO coverage for HSCT, and more. Explore here: ashpublications.org/blood/is…
4
11
1,623
PACSIN2 facilitates clathrin-mediated transferrin receptor (CD71) internalization during terminal erythroid maturation. PACSIN2 deficiency results in mild hypochromic microcytic anemia, altered EBI macrophages, and splenic iron accumulation. ow.ly/IJQ050ZZ77l
335
Blood Journals Portfolio retweeted
Very happy to have participated in this podcast with @BloodPortfolio about our new paper on the phase 2 trial of TAG-AZA-VEN for #BPDCN bloodpodcast.transistor.fm/e…
2
10
652
New episode of the Blood Podcast out now discussing new drug combinations for #BPDCN and reduced intestinal dysbiosis after #HSCT. Dr. Laurie Sehn interviews Drs. Andrew Lane of @DanaFarber and Pooja Khandelwal of @CincyChildrens on their latest research:
bloodpodcast.transistor.fm/e…
2
4
1,420
Immediate implant reconstruction after mastectomy yielded 54% lower DVT and 33% lower hematoma rates. Procedural complexity alone does not determine clotting and bleeding risk after breast cancer surgery; patient selection matters. Read in Blood VTH: ow.ly/ZubZ50ZZ7zc
2
3
7
1,266
Blood Journals Portfolio retweeted
@RhysMorganLab & @oknsvm in @BiochemBiomedUS, and David Palmer at @BSMSMedSchool feature in new research out this week in @ASH_hematology @BloodPortfolio
The study led by Profs @andiroy & @milnetom68 at @MRC_WIMM show LIN28B's role in infant B-ALL. 👊
ashpublications.org/blood/ar…
2
5
344
"Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials" read the review article in Blood VTH: ow.ly/i3v250ZZ7qO
1
4
20
1,802
An Hb and heme-binding ApoHb-Hp complex protects the heart and kidneys from injury caused by chronic hemolysis. Female mice show partial natural resilience to hemolysis, and both sexes benefit from ApoHb-Hp treatment. Read in Blood RCI: ow.ly/GmTN5101LGT
1
1
6
1,073
NEW in Blood Advances! American Society of Hematology 2026 guidelines for immune thrombocytopenia: initial and second-line therapy for adults with primary ITP ow.ly/Prx55101LvP #clinicalguidelines #ITP #bloodadvances
23
83
5,295
There is an unmet need to overcome resistance to venetoclax in #AML, particularly in the context of TP53 mutations. Pitavastatin enhances venetoclax cytotoxicity in AML cell lines and primary samples, including those with common mechanisms of resistance. ow.ly/WgXW50ZZ37A
1
12
35
2,293
The SickleFit virtual exercise intervention is feasible and highly enjoyable for adults aged ≥40 years with #SCD. Participants demonstrated improvements in physical performance, with 65% showing increased endurance on 6-minute walk. Read in Blood RCI: ow.ly/1otc5101rww
1
6
1,138
New issue of Blood Advances out now! Featuring A next-generation FVIIIa mimetic in the making, A comprehensive review of T-cell lymphoma following CAR T-cell immunotherapy, and more. Explore here: ashpublications.org/bloodadv…
5
11
1,547
In comparison of DEC vs AZA, there was no difference in OS or LFS for patients with #MDS. There were no major differences in transfusion dependence or QoL metrics for patients treated with DEC vs AZA. Read in Blood Neoplasia: ow.ly/pes050ZZ33A
7
15
2,219
Blood Journals Portfolio retweeted
📰 New network publication! 🗞️
Congrats to Prof @andrea_pepper2, Dr Emma Kennedy and team in @BSMSMedSchool for their publication in @ASH_hematology @BloodPortfolio.
Study identifies distinct CLL subgroups and assays for predicting BTKi sensitivity. 👊
ashpublications.org/blood/ar…
3
4
606
Plasma serotonin is cleared even after SERT inhibition, indicating compensatory, SERT-independent pathway(s) can maintain serotonin balance. Read the full article in Blood VTH: ow.ly/kJJ750ZZ7o6
2
3
1,127
This is, to our knowledge, the first large-scale quantitative characterization of TET2 VAF as a continuous prognostic variable in #CMML. Read the full multicenter study in Blood Neoplasia: ow.ly/hcWF50ZZ7p8
8
19
2,039
Blood Journals Portfolio retweeted
Officially out! Prognostic implications of #TET2 variant allele frequency in chronic myelomonocytic leukemia: a multicenter study
doi.org/10.1016/j.bneo.2026.…
#MDSsm #MPNsm #CMML
@Bloodneoplasia @BloodPortfolio @aamdsif @MDSFoundation @ic_MDS
7
20
1,285
Blood Journals Portfolio retweeted
A comparison of overall survival and quality of life in patients with MDS treated with azacytidine vs decitabine
doi.org/10.1016/j.bneo.2026.…
#MDSsm @aamdsif @MDSFoundation @ic_MDS @BloodPortfolio @Bloodneoplasia
2
4
9
1,260
asxl1 and IDH2R172K comutation epigenetically silences tet2 and activates the MAPK and AP-1 pathways in leukemia. Targeting DNA methylation, ROS, MAPK, and AP-1 mitigates leukemogenesis associated with asxl1 and IDH2R172K comutations in zebrafish. ow.ly/fI3K50ZZ2bW
2
4
9
1,691